Injection subcutaneous

Pituitary Dwarfism. Pituitary dwarfism is a condition characterized by an inabiHty to produce or secrete normal levels of endogenous hGH. The condition results in reduced heights of individuals afflicted with the condition and has been treated by intramuscular or subcutaneous injection of hGH. Pituitary hGH was used prior to the approval of biosynthetic hGH. If treatment is initiated early enough, the patient can attain a final adult height weU within the normal range. 

Subcutaneous injection of 100—750 mg/kg sulfolane at an ambient temperature of 10°C also caused a dose-dependent decrease in colonic temperature of rabbits. MetaboHc rate remained unchanged during the initial phase of the hypothermia for all dose groups but peripheral vasodilatation, as indicated by an increase in ear skin temperature, was seen at the higher dose levels (29). 

In order to induce a toxic effect, local or systemic, the causative material must first come into contact with an exposed body surface these are the routes of exposure. In normal circumstances, and depending on the nature of the material, the practical routes of exposure are by swallowing, inhalation, and skin and eye contact. In addition, and for therapeutic purposes, it may be necessary to consider intramuscular, intravenous, and subcutaneous injections as routes of adininistration. 

Of the other Strychnos alkaloids vomicine has been investigated by Ruickoldt, who finds that in mice and rabbits it causes clonic convulsions, due to stimulation above the level of the anterior corpore quad-ragemina. Convulsions can be elicited after intravenous, but not after subcutaneous, injections. The toxicity is low twelve times the convulsive dose does not cause death. No special action is exerted on blood... 

Toxicity. MEDINA is apparently non-toxic to rabbit penile mucosa its cumulative effect on abraded and intact rabbit skin is slightly greater than Tetryl no damage was observed to rabbit cornea and there was no evidence of sensitization by subcutaneous injection in guinea pigs. It was concluded that its toxicity is similar to that of Tetryl (Ref 11, p 138)... 

FIGURE 2-6. Stes on the body at which subcutaneous injections can be given. 

The first study to demonstrate the activity of enfuvirtide in HIV-infected patients (Kilby et al. 1998) showed that patients receiving the maximum 100 mg intravenous dose had maximum median declines in HIV-1 RNA of -1.96 logjo copies/mL through 14 days. Several additional studies (Kilby et al. 2002 Lalezari et al. 2003a, b) further demonstrated the safety and efficacy of enfuvirtide and led to the selection of twice-daily subcutaneous injections of a 90 mg nominal dose for testing in the TORO (T-20 vs. optimized regimen only) pivotal clinical trials. 

Subcutaneous injection of insulin encapsulated in liposomes in rats resulted in prolonged hypoglycemic effects compared to a solution of free insulin this study also indicated that a substantial fraction of hand-shaken multilamellar vesicles could enter the circulation in intact form after subcutaneous injection (Stevenson et al., 1982). The neutral liposomes used in this study were cleared more slowly from the injection site than the negatively charged liposomes. 

Breit S, Rueff F, PrzybiUa B Deep impact contact allergy after subcutaneous injection of local anesthetics. Contact Dermatitis 2001 45 296-297. Orasch CE, Helbling A, Zanni MP, Yawalkar N. Hari Y Pichler WJ T-cell reaction to local anaesthetics relationship to angioedema and urticaria after subcutaneous application-patch testing and LTT in patients with adverse reaction to local anaesthetics. Clin Exp Allergy 1999 29 1549-1554. 

Simons PER, GuX, Simons KJ Epinephrine absorption in adults intramuscular versus subcutaneous injection. J Allergy Chn Immunol 2001 108 871- 27 873. 

It is not surprising that intramuscular injection of epinephrine into the vastus lateralis produces a prompt peak plasma epinephrine concentration, because of the large size and excellent vascularization of this muscle. It is also not surprising that subcutaneous injection of epinephrine potentially leads to delayed absorption, because of the potent Ui-adrenergic agonist vasoconstrictor effects in the skin and subcutaneous tissue, as evidenced by skin blanching at the injection site [19, 20]. 

Some types of injections must be made iso-osmotic with blood serum. This applies particularly to large-volume intravenous infusions if at all possible hypotonic solutions cause lysis of red blood corpuscles and thus must not be used for this purpose. Conversely, hypertonic solutions can be employed these induce shrinkage, but not lysis, of red cells which recover their shape later. Intraspinal injections must also be isotonic, and to reduce pain at the site of injection so should intramuscular and subcutaneous injections. Adjustment to isotonicity can be determined by the following methods. 

Figure 7A shows the timeeourse of [ H]MDA accumulation and clearance from rat brain after a subcutaneous injection. Peak concentration, which was reached at 45 minutes, was equivalent to 165 (36 trg/g). To... 

In initial ICC studies, animals were treated with MDA or MDMA using the protocol described by Ricaurte et al. (1985). Adult Sprague-Dawley rats (150 to 200 g) reeeived subcutaneous injections of racemic MDA or MDMA every 12 hours for 4 days. Each dose was equivalent to 20 mg/kg of the free base. The rats were sacrificed by intracardiac aldehyde perfusion 2 weeks after the final dose. In order to study subacute effects for evidence of degeneration, additional rats received MDA every 12 hours for 2 days and were sacrificed 24 hours after the last injection. Additional experimental details are described elsewhere (O Heam et al. 1986 O Heam et al. 1988). A series of animals treated identically and in parallel were analyzed for changes in 5-HT levels and density of uptake sites using paroxetine binding (Yeh et al. 1986 Battaglia et al. 1987). 

---